#esmo22 highlights on neoadjuvant ici in locally advanced dmmr colon cancer: the niche-2 study
Published 1 year ago • 4.1K plays • Length 2:46Download video MP4
Download video MP3
Similar videos
-
2:17
#esmo22 highlights on pembrolizumab with crt in locally advanced hnscc: the keynote-412 study
-
5:30
expert report on immune checkpoint inhibitors for dmmr colorectal cancer
-
2:22
#esmo22 highlights on neoadj. vs adjuvant pembrolizumab in resected stage iii-iv melanoma:swog s1801
-
3:16
#esmo22 highlights on tils versus ipilimumab in patients with advanced melanoma: the phase 3 study
-
7:29
myriam chalabi, esmo 2022: neoadjuvant immune checkpoint inhibition in mmr-deficient colon cancer
-
2:30
#esmo22 highlights on first-line atezolizumab in nsclc not eligible for platinum: the ipsos study
-
0:55
esmo 2022 highlights
-
3:35
#esmo22 highlights on actionable inflammatory axis for air pollution induced nsclc
-
7:00
expert report on neoadjuvant immune checkpoint inhibitors for nsclc
-
2:45
esmo 2020 highlights on neoadjuvant mfolfirinox for t3-4 rectal cancer: the prodige 23 study
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
2:56
#esmo22 highlights on cabozantinib with nivo and ipi for intermediate/poor risk adv. rcc: cosmic-313
-
2:27
esmo 2020 highlights on neoadjuvant ici in early tnbc: the impassion031 study
-
2:21
#esmo22 highlights on adt duration with post-operative radiotherapy in prostate cancer: radicals-hd
-
2:56
#esmo22 highlights on nirogacestat in patients with progressing desmoid tumours: the defi study
-
3:17
highlights on adjuvant chemotherapy of stage ii colon cancer: the dynamic trial
-
25:09
kidney cancer highlights from esmo 2022
-
1:49
highlights in colorectal cancer from esmo wcgic 2022